AzTrials
AzTrials

AnxietyPhase 3NCT03069677

Music vs Midazolam During Preop Nerve Block Placement

A Phase 3 study testing music and Midazolam in people with Anxiety and Peripheral Nerve Block, run by University of Pennsylvania at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine if there are differences in anxiety scores, heart rate, blood pressure, and oxygen status when using sedation medication versus music while undergoing a peripheral nerve block before your surgery. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Anxiety, Peripheral Nerve Block
What is being tested?
music and Midazolam
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
160 participants
Where
1 siteUnited States
Study dates
12 Apr 2017to 11 May 2018
Phase
Phase 3
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients who are >18 years of age, who will give informed consent in receiving a peripheral nerve block in the preoperative bay for their primary anesthetic and/or for their postoperative pain control.

Who cannot join

  • significant psychiatric disorder such as generalized anxiety disorder, panic disorder, depression, psychosis, bipolar disorder; individuals who were incompetent to give informed consent; pregnant and/or breast feeding patients; any underlying coagulopathy, infection or other factors which would be a contraindication to receiving a peripheral nerve block; hypersensitivity to midazolam; and history of renal impairment. Patients who were extremely anxious (scores 50 and greater on the State Trait Anxiety Inventory-6 (STAI-6) tool) were also excluded from the study.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Pennsylvania

    Philadelphia, Pennsylvania, 19104

Other trials in United States

About this study

Official title: Music vs Midazolam During Preoperative Nerve Block Placement: A Prospective, Randomized Controlled Study

The purpose of this study is to determine if there are differences in anxiety scores, heart rate, blood pressure, and oxygen status when using sedation medication versus music while undergoing a peripheral nerve block before your surgery.

Read the detailed description

The general flow of the study will be conducted as follows:

  1. Research coordinator will call or approach patients who are scheduled for a surgical procedure that is planning for a peripheral nerve block either for the primary anesthetic or for postoperative pain control to be placed in the preoperative bay in the ambulatory surgical center.
  2. Research coordinator will discuss the purpose of our study and explain the study in detail for the patient. If a patient agrees to participate, then we will have the patient sign the informed consent for the study. If patient is on the phone and decides to participate, the patient will sign the informed consent upon arriving to Penn Medicine University City (PMUC).
  3. Once the patient signs the informed consent for the peripheral nerve block by anesthesia team. The patient randomized will be revealed to either music or IV midazolam. The pre-procedure anxiety score will then be obtained using the STAI-6 validated tool.
  4. The golden moment will be conducted between the patient, provider, and nursing staff. Once this golden moment is completed, the anxiolytic intervention will start (music or IV midazolam)*
  5. The preoperative nerve block will be conducted by the regional anesthesia block team.
  6. Once the nerve block is complete, we will obtain the post-procedure anxiety score using the STAI-6 validated tool.
  7. Once the post-procedure anxiety score has been obtained, we will also obtain the patient satisfaction score, the provider satisfaction score, and the evaluation of any difficulties in communication between the provider and patient. After these questions have been obtained, the study is complete.
Being tested
music, Midazolam
Keywords
midazolam
Medical subject headings
Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • musicOther

    patients in this group will receive research-selected music after the golden moment has been completed between the patient, provider, and nursing staff

  • MidazolamDrug

    Also called Hypnovel

    patients in this group will receive IV midazolam (1mg to 2mg max) after the golden moment has been completed

Study groups in NCT03069677
Study groupRoleWhat they receive
Music groupActive comparatorresearch-selected music
Receives: Other: music
Midazolam groupActive comparatorIV midazolam (1mg to 2mg max)
Receives: Drug: Midazolam

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Anxiety Levels

    Spielberger State-Trait Anxiety Inventory 6

    Scale range is from 20 to 80. Higher the score, the higher the anxiety level is.

    Measured: 1-2 minutes before conducting golden moment for nerve block placement and immediately after nerve block placement (less than 1 minute after)

  2. Change in STAI-6 Scores From Post to Pre.

    Spielberger State-Trait Anxiety Inventory 6

    Scale range is from 20 to 80. Higher the score, the higher the anxiety level is.

    Measured: 1-2 minutes before conducting golden moment for nerve block placement and immediately after nerve block placement (less than 1 minute after)

Secondary outcomes (4)
  1. Patient Satisfaction Scores of the Experience During Procedure

    survey which assess satisfaction on a 10-point numeric rating scale

    Scale ranges from 0 to 10. A higher number indicates a higher satisfaction

    Measured: immediately after nerve block placement (less than 1 minute after)

  2. Provider Satisfaction Scores of the Experience During Procedure

    survey which assess satisfaction on a 10-point numeric rating scale

    Scale ranges from 0 to 10. A higher number indicates a higher satisfaction

    Measured: immediately after nerve block placement (less than 1 minute after)

  3. Evaluation of Difficulties in Communication From Provider to Patient and Patient to Provider

    surveyed on a 5-point Likert scale

    Scale ranges from 1 to 5; the higher the number, the more difficult it is to communicate.

    Measured: immediately after nerve block placement (less than 1 minute after)

  4. Block Times

    differences amongst music and midaz group

    Measured: immediately after nerve block placement (less than 1 minute after)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Mar 2017
  2. Study start12 Apr 2017
  3. Primary completion11 May 2018
  4. Study completion11 May 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
1:1
Masking
None (open label)
Enrolment
160 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03069677
Sponsor's protocol ID
826754
Status last verified
Sep 2019
First submitted
22 Feb 2017
Last updated
10 Sep 2019
Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
Individual data sharing
No

Publications

  • Graff V, Cai L, Badiola I, Elkassabany NM. Music versus midazolam during preoperative nerve block placements: a prospective randomized controlled study. Reg Anesth Pain Med. 2019 Jul 18:rapm-2018-100251. doi: 10.1136/rapm-2018-100251. Online ahead of print.

    PubMed 31320504

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing music and Midazolam in people with Anxiety and Peripheral Nerve Block, run by University of Pennsylvania at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Sep 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Yes. Results are posted in the registry (first posted 10 Sep 2019). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Anxiety Levels (time frame: 1-2 minutes before conducting golden moment for nerve block placement and immediately after nerve block placement (less than 1 minute after)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03069677, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Sep 2019; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in